Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah.
Oper Neurosurg (Hagerstown). 2020 Nov 16;19(6):659-666. doi: 10.1093/ons/opaa227.
Isolated trigeminal schwannomas occur in 0.07% to 0.3% of intracranial tumors and account for 0.8% to 8% of intracranial schwannomas and 1/3 of Meckel cave tumors. The presence of multisegmental schwannoma is rare, resulting in a limited understanding of its optimal management.
To describe potential surgical options to manage this rare entity.
A 2-institution retrospective review of all patients with pathologically confirmed trigeminal schwannoma managed with resection from January 2009 through January 2019 was conducted. A manual chart review was performed to verify patients' inclusion and collect data about age, sex, tumor size, tumor site, treatment modality, surgical approach, complications, and follow-up duration and status.
A total of 4 patients (age range 12-50 yr) who underwent a variety of cranial and orbitocranial approaches for tumor resection were identified. Patients achieved good outcomes with improvement of visual outcomes. One case of infection and 1 case of partial tumor recurrence requiring reresection were identified.
Multisegmental trigeminal schwannoma is a rare and unique entity, often associated with trigeminal schwannomatosis. Interdisciplinary management has been shown to be the most effective method for improving patient outcomes with these complex and poorly understood diseases.
孤立性三叉神经鞘瘤占颅内肿瘤的 0.07%至 0.3%,占颅内神经鞘瘤的 0.8%至 8%,占 Meckel 腔肿瘤的 1/3。多节段神经鞘瘤较为罕见,因此对其最佳治疗方法的了解有限。
描述管理这种罕见实体的潜在手术选择。
对 2009 年 1 月至 2019 年 1 月期间,通过病理证实并接受手术切除的所有三叉神经鞘瘤患者进行了 2 个机构的回顾性研究。进行了手动图表审查以验证患者的纳入情况,并收集有关年龄、性别、肿瘤大小、肿瘤部位、治疗方式、手术途径、并发症以及随访时间和状态的数据。
共确定了 4 例(年龄范围为 12-50 岁)患者,他们接受了各种颅和眶颅入路进行肿瘤切除。所有患者均取得了良好的结果,视力得到了改善。有 1 例感染和 1 例部分肿瘤复发需要再次切除。
多节段三叉神经鞘瘤是一种罕见且独特的实体,常与三叉神经鞘瘤病有关。多学科管理已被证明是改善这些复杂且了解甚少的疾病患者预后的最有效方法。